acl at investor conference - new york

This could have something to do with looking at investors for our phase 3 trials of HA-irinotecan. Makes sense if they can get the funding to get it happening sooner rather than later, ie: wait for fonda revenues to stream in.

http://www.rodm.com/conferences?id=30&link=presenters

We are pleased to inform you of the Rodman & Renshaw 11th Annual Healthcare Conference, to be held on September 9-11, 2009 at the New York Palace Hotel, in New York, NY.

Key Note Speaker DR.Alan Greenspan
Former Chairman of the Federal Reserve

The conference features:

Corporate Presentations
Q&A Sessions
Investor One-on-One Meetings
Partnering One-on-One Meetings
Equity Analysts to Chair Each Track
Daily Networking Opportunities over Breakfast, Lunch and Cocktails

Attendees:

Institutional Investors
Venture Capitalists
Sophisticated Private Investors
Industry Executives
Business Development and Partnering Executives
Private Equity Firms
PRESENTATION INFORMATION

Length and content:

Company presentations will be approximately 20 minutes in length, followed by a 5-minute Q & A session and one-on-one investor and partnering meetings. In preparing your presentation, please keep in mind that you are presenting to investors with a familiarity of biotechnology and life sciences investing. Focus on the points that make your company an attractive investment opportunity.